Rubius Therapeutics Raises $100 Million in Crossover Financing Post author:Sam Post published:February 28, 2018 Post category:BioPharma Rubius Therapeutics has closed on an oversubscribed $100 million crossover financing. Source: BioSpace You Might Also Like Nabriva Reports Second Quarter 2017 Financial Results And Recent Corporate Highlights August 6, 2017 Biotech Startup Gets Grant to Triple Its Workforce August 14, 2017 With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO May 15, 2017
With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO May 15, 2017
